Viewing Study NCT02879305

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:37 AM
Ignite Modification Date: 2026-04-23 @ 5:01 PM
Study NCT ID: NCT02879305
Status: COMPLETED
Last Update Posted: 2021-12-03
First Post: 2016-08-22
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anaemia View
None Aspergillosis, Allergic Bronchopulmonary View
Keywords:

Keywords

Keyword Brief Keyword Text View
None erythropoiesis stimulating agents View
None GSK1278863 View
None daprodustat View
None anemia View
None chronic kidney disease View
None hemoglobin View
None recombinant human erythropoietin View